LON002

· LondonPharma Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LON002, covering 2015-03-18 to 2015-09-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours [Phase 1, Phase 2]